Atlas Trials

Influence of Cytochrome P2B6 on Efavirenz Dose in HIV-infected Thai Patients

Clinical trial NCT02421289 · UNKNOWN

Trial details

NCT number
NCT02421289
Sponsor
Mahidol University
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Cytochrome P-450 CYP2B6EfavirenzHIV
Start date
2013-04-01
Primary completion
2014-04-01
Enrollment
190

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.